Uede T, Ishizaka K
J Immunol. 1984 Jul;133(1):359-67.
Normal spleen cells from high IgE responder, BDF1 mice, formed IgE-potentiating factor upon incubation with mouse IgE, whereas those from low IgE responder, SJL mice, formed IgE-suppressive factor. The majority of the factors from BDF1 spleen cells had affinity for lentil lectin; those from SJL mice lacked affinity for the lectin. BDF1 spleen cells could be switched, however, to form IgE-suppressive factor if the cells were incubated with IgE in the presence of lipomodulin , a phospholipase inhibitory protein. In contrast, SJL spleen cells could form IgE-potentiating factor in the presence of lysolecithin, which enhances the glycosylation of IgE-binding factors. When the two strains were primed with alum-absorbed ovalbumin and their spleen cells were stimulated with homologous antigen, IgE-binding factors were detected in culture filtrates. The factors formed by BDF1 spleen cells selectively potentiated the IgE response, however, whereas those formed by SJL spleen cells selectively suppressed the response. Analysis of the cellular mechanisms for the selective formation of IgE-potentiating factor by antigen-primed BDF1 spleen cells revealed that antigenic stimulation of Lyt-1+ T cells resulted in the formation of two T cell factors, i.e., an "inducer" of IgE-binding factor and a glycosylation-enhancing factor, and that these factors induced the selective formation of IgE-potentiating factor. In SJL spleen cells, antigenic stimulation of Lyt-1+ T cells resulted in the formation of an "inducer" and a glycosylation-inhibiting factor, and those factors in turn stimulated the formation of IgE-suppressive factor. An additional difference between the two strains was found in Fc gamma R+ Ly-1+ T cells that were the cell source of IgE-binding factors. Upon stimulation with IgE or "inducer", BDF1 Lyt 1+ cells formed IgE-potentiating factor, whereas the same subset of T cells from SJL mice formed IgE-suppressive factor. The results indicate that the genetic differences between the two strains with respect to the nature of IgE-binding factors appear to be expressed in the process of glycosylation of IgE-binding factors.
来自高IgE应答的BDF1小鼠的正常脾细胞,与小鼠IgE孵育后会形成IgE增强因子,而来自低IgE应答的SJL小鼠的脾细胞则会形成IgE抑制因子。BDF1脾细胞产生的大多数因子对扁豆凝集素有亲和力;而SJL小鼠的因子则缺乏对该凝集素的亲和力。然而,如果BDF1脾细胞在磷脂酶抑制蛋白脂调素存在的情况下与IgE一起孵育,它们可以转而形成IgE抑制因子。相反,SJL脾细胞在溶血卵磷脂存在的情况下可以形成IgE增强因子,溶血卵磷脂可增强IgE结合因子的糖基化。当这两个品系用明矾吸附的卵清蛋白进行致敏,并用同源抗原刺激它们的脾细胞时,在培养滤液中检测到了IgE结合因子。然而,BDF1脾细胞产生的因子选择性地增强了IgE应答,而SJL脾细胞产生的因子则选择性地抑制了该应答。对抗原致敏的BDF1脾细胞选择性形成IgE增强因子的细胞机制分析表明,Lyt-1+ T细胞的抗原刺激导致形成两种T细胞因子,即IgE结合因子的“诱导剂”和糖基化增强因子,并且这些因子诱导了IgE增强因子的选择性形成。在SJL脾细胞中,Lyt-1+ T细胞的抗原刺激导致形成一种“诱导剂”和一种糖基化抑制因子,而这些因子反过来又刺激了IgE抑制因子的形成。在作为IgE结合因子细胞来源的FcγR+ Ly-1+ T细胞中发现了这两个品系之间的另一个差异。在用IgE或“诱导剂”刺激后,BDF1 Lyt 1+细胞形成IgE增强因子,而来自SJL小鼠的相同T细胞亚群则形成IgE抑制因子。结果表明,这两个品系在IgE结合因子性质方面的遗传差异似乎在IgE结合因子的糖基化过程中得以体现。